Related Experiment Video
Updated: Jul 9, 2025

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
Structural characterization of M8C10, a neutralizing antibody targeting a highly conserved prefusion-specific epitope
Xiao Xiao1,2,3, Zhiyun Wen1, Qing Chen4
1Infectious Diseases and Vaccines Discovery, Merck & Co., Inc., West Point, Pennsylvania, USA.
Importance:
Human metapneumovirus (hMPV) is a common pathogen causing lower respiratory tract infections worldwide and can develop severe symptoms in high-risk populations such as infants, the elderly, and immunocompromised patients. There are no approved hMPV vaccines or neutralizing antibodies available for therapeutic or prophylactic use. The trimeric hMPV fusion F protein is the major target of neutralizing antibodies in human sera. Understanding the immune recognition of antibodies to hMPV-F antigen will provide critical insights into developing efficacious hMPV monoclonal antibodies and vaccines.
Insights
Human metapneumovirus (hMPV) causes severe respiratory infections globally. Research into the hMPV fusion F protein is crucial for developing effective vaccines and antibody therapies against this common viral pathogen.
Area of Science:
- Virology
- Immunology
- Infectious Diseases
Background:
- Human metapneumovirus (hMPV) is a significant global cause of lower respiratory tract infections.
- Severe illness from hMPV disproportionately affects vulnerable groups, including infants, the elderly, and immunocompromised individuals.
- Currently, no specific vaccines or neutralizing antibody treatments are approved for hMPV prevention or therapy.
Purpose of the Study:
- To investigate the immune recognition of the hMPV fusion (F) protein.
- To identify key targets for developing neutralizing antibodies against hMPV.
- To provide insights for the creation of effective hMPV vaccines and antibody-based therapeutics.
Main Methods:
- Analysis of antibody binding and neutralization epitopes on the hMPV F protein.
- Characterization of the structural and functional properties of the hMPV F protein.
- Immune response profiling against hMPV antigens.
Main Results:
- The trimeric hMPV F protein is identified as the primary target for neutralizing antibodies found in human serum.
- Specific epitopes on the F protein are crucial for antibody-mediated viral neutralization.
- Detailed understanding of antibody interactions with the F protein.
Conclusions:
- Understanding antibody recognition of the hMPV F protein is essential for therapeutic and prophylactic strategies.
- This knowledge will guide the development of novel monoclonal antibodies and vaccines against hMPV.
- Targeting the hMPV F protein offers a promising avenue for combating hMPV infections.
More Related Videos
07:53A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019
08:40Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
Related Concept Videos
Tagging and Fusion Proteins
Leaky Scanning